Lecture 12: Advanced Pharmacology: Nuclear Receptors Classification, Structure, and Therapeutic Applications

Introduction to Nuclear Receptors and Module Overview

• Module Transition: This lecture concludes the second module of the unit. The upcoming third module will focus on the "bedside" application of pharmacology, specifically covering adverse drug reactions (ADRs) and drug-related toxicities.

• Core Concepts Outlook: Three core concepts of pharmacology remain to be addressed in the final lectures of the unit:

  • Adverse drug reactions (ADRs).

  • Therapeutic index.

  • Individual variation in drug response.

• Research Milestones: Nuclear receptor research is categorized by key themes: classification, general structure, response elements, RXR (Retinol X Receptor) heterodimers, co-factors/co-regulators (co-activators and co-repressors), and xenobiotic receptors.

Fundamental Properties of Nuclear Receptors

• Functional Definition: Nuclear receptors are ligand-activated transcription factors. They are activated only upon the binding of a specific ligand.

• Comparison to Other Families: Unlike the other three receptor superfamilies where binding occurs extracellularly, ligand binding for nuclear receptors occurs intracellularly.

• Ligand Requirements: Ligands for nuclear receptors must possess high lipophilicity to diffuse across the cell membrane to reach the receptor.

• Mechanism of Action: Nuclear receptors interact directly with DNA to regulate the transcription of target genes. This lack of complex signal transduction cascades (unlike G-protein coupled receptors or kinase-linked receptors) is a defining feature. There are currently 40 known nuclear receptors.

• Gene Regulation: Regulation is achieved through the recognition of specific DNA sequences known as response elements.

Classification of Nuclear Receptors

• Class I: Steroid Nuclear Receptors:

  • Examples: Glucocorticoid, androgen, and estrogen receptors.

  • Dimerization: They form homodimers (two identical monomeric receptors).

  • Location: Typically reside in the cytoplasm when inactive, forming a complex with chaperone proteins like Heat Shock Proteins (HSP90). Upon ligand binding, they translocate to the nucleus.

  • Response Element Recognition: They recognize "inverted repeat" DNA patterns. An inverted repeat consists of two half-sites separated by a spacer, where the second sequence is the reverse complement of the first (e.g., $AGG\,TCA$ and its complementary flipped sequence $TGA\,CCT$).

• Class II: RXR Heterodimers:

  • Ligands: Respond to lipids, fatty acids, or cholesterol.

  • Dimerization: One partner is always the Retinol X Receptor (RXR). Together, they form a heterodimer.

  • Location: Typically reside constitutively within the nucleus.

  • Response Element Recognition: They recognize "direct repeat" DNA patterns, where the half-site sequences are identical and repeat in the same direction (e.g., $AGG\,TCA$ followed by $AGG\,TCA$).

• Classes III and IV: Orphan Nuclear Receptors:

  • Orphan Status: Named because their endogenous ligands are unknown, or they bind to an overwhelming number of ligands, making functional isolation difficult. Some are constitutively active (demonstrate activity without any ligand binding).

  • Dimerization: Class III typically forms dimers (homo or hetero), while Class IV exists as monomers.

  • Location: Reside in the nucleus.

  • Response Element Recognition: Class III recognizes direct repeats. Class IV recognizes a single, extended half-site.

General Structure and Functional Domains

• A/B Domain (N-terminal Domain):

  • Conservation: The least conserved region in terms of both length and amino acid sequence.

  • AF1 (Activation Function 1): Located in this domain. It binds co-regulators (co-activators or co-repressors) in a ligand-independent manner.

• C Domain (DNA Binding Domain - DBD):

  • Conservation: Highly conserved across the superfamily.

  • Zinc Fingers: Characterized by two zinc fingers. Each consists of a $Zn^{2+}$ ion coordinated by four cysteine residues.

  • Function of Fingers: The first zinc finger binds the specific DNA response element; the second is involved in receptor dimerization.

• D Domain (Hinge Region):

  • Structure: A flexible linker between the DBD and the ligand-binding domain.

  • Nuclear Localization Signal (NLS): Contains the NLS, essential for guiding the translocation of receptors from the cytoplasm back into the nucleus.

• E/F Domain (Ligand Binding Domain - LBD):

  • Conservation: Fairly conserved.

  • Structure: Contains 12 alpha-helices forming a hydrophobic binding pocket.

  • Alpha-Helix 12: Acts as a molecular switch. Its position changes depending on whether an agonist or antagonist is bound. This shift determines if the receptor recruits a co-activator or a co-repressor.

  • AF2 (Activation Function 2): Found in the LBD. It binds co-regulators in a ligand-dependent manner, requiring the conformational change induced by ligand binding.

  • Dimerization: Also plays a role in receptor dimerization.

Dynamics and Time Scale of Action

• Example: Androgen Receptor (AR): When fused with Green Fluorescence Protein (GFP), the AR can be seen moving from the cytoplasm to the nucleus upon stimulation by an agonist.

• Translocation Timing: At 6 minutes post-stimulation, significant movement is visible. By 30 to 60 minutes, the receptor is exclusively found in the nucleus.

• Full Functional Effect: While translocation occurs within an hour, the downstream physiological results (protein synthesis) operate on a time scale of hours to days.

Specific Example: The Glucocorticoid Receptor (GR)

• HPA Axis: The Hypothalamus-Pituitary-Adrenal axis regulates the release of glucocorticoids in response to stress. Endogenous glucocorticoids provide negative feedback to the hypothalamus and pituitary to maintain homeostasis.

• Clinical Relevance: Glucocorticoids are anti-inflammatory and immunosuppressive. Synthetic versions are used to treat inflammatory and immune-related diseases.

• Isoforms: $GR\alpha$ (the primary physiological form) and $GR\beta$. Other variants exist, such as $GR\alpha\text{-}\\gamma$, which features an arginine insertion in the DBD.

• GR Signaling Mechanisms:

  • Cytoplasmic Complex: In the absence of a ligand, the receptor is bound to Heat Shock Protein 90 (HSP90).

  • Non-genomic Signaling: Dissociation can trigger rapid pathways like MAPK, PI3K, or AKT (not the primary focus of this lecture).

  • Genomic Signaling: Transactivation (increasing gene expression) and Transrepression (suppressing gene expression).

• Mechanisms of Transcription Regulation:

  • Direct Interaction: Binding to positive or negative response elements ($GRE$/$nGRE$). Glucocorticoid REs are typically imperfect inverted repeats (e.g., $GGTACAnnnTGTTCT$).

  • Interacting with Pro-inflammatory Transcription Factors: Target factors including Activated Protein 1 (AP-1) and Nuclear Factor Kappa B (NF-kB).

  • Tethering: The GR binds to AP-1 or NF-kB that is already bound to DNA, suppressing their activity without the GR touching the DNA itself.

  • Composite: The GR binds its own response element and interacts with a neighboring DNA-bound AP-1 or NF-kB.

Specific Example: PPAR Gamma and Insulin Sensitivity

• PPAR (Peroxisome Proliferator-Activated Receptor): A Class II receptor utilizing RXR heterodimers.

• Heterodimer Activation Types:

  • Non-permissive: The RXR is silenced. Activation requires ligand binding to the partner receptor (e.g., Thyroid receptor). RXR ligand binding alone is insufficient.

  • Permissive: Can be activated by a ligand for either partner. Presence of ligands for both creates a synergistic effect.

• PPAR Gamma Function: Involved in lipid metabolism and glucose homeostasis. It serves as a target for treating Type 2 Diabetes.

• Mechanism of Sensitization: Activation increases the transcription of genes for proteins involved in insulin action:

  • Glucose Transporter 4 (GLUT4).

  • PI3K and AKT signaling components.

  • Insulin Receptor Substrates (IRS).

• Biological Result: Increased glucose uptake in skeletal muscles and reduced gluconeogenesis in the liver, effectively lowering blood glucose.

Xenobiotic Sensors

• Sensory Role: Certain Class II nuclear receptors act as sensors for foreign chemicals (xenobiotics).

• Key Receptors: Pregnane X Receptor (PXR) and Constitutive Androstane Receptor (CAR).

• Induction: Upon binding a drug, these receptors form RXR heterodimers and increase the transcription of target genes involved in drug metabolism and excretion:

  • Cytochrome P450 (CYP) enzymes.

  • Phase II enzymes like UDP-glucuronosyltransferase (UGT).

  • Drug transporters such as P-glycoprotein (MDR1).

• Clinical Link: This explains the mechanism behind CYP induction, as opposed to CYP inhibition.

Questions & Discussion

• Question: Can you give an example of a transcription factor mentioned in the previous lecture related to signal transduction?

• Response: The STAT protein (Signal Transducer and Activator of Transcription). It is linked to cytokine receptors and the JAK/STAT signaling pathway. Unlike nuclear receptors, STATs are activated by phosphorylation via kinases rather than direct ligand binding to the transcription factor itself.

• Question: What is the difference between the 30-minute and 60-minute mark in the GFP translocation images?

• Response: At 30 minutes, translocation is still incomplete, as some fluorescence remains in the cytoplasm. By 60 minutes, the receptors are exclusively found in the nucleus, represented by the disappearance of cytoplasmic fluorescence.